Chlamydia Vaccine (Recombinant) from China
This recombinant chlamydia vaccine uses the major outer membrane protein (MOMP) produced through biotechnological processes, combined with an adjuvant. It is designed to prevent trachoma and sexually transmitted chlamydial infections. As a vaccine obtained by biotechnological means, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
Duty Rate — China → Canada
0%
Import Tips
• Provide a certificate of analysis confirming the recombinant nature of the vaccine
• Check if the product requires a clinical trial authorization from Health Canada if imported for research
• Ensure proper labeling in English and French as per Canadian regulations